Development and Validation of a Simple, Rapid and Inexpensive PCR-RFLP Method for Genotyping of Common IL28B Polymorphisms: A Useful Pharmacogenetic Tool for Prediction of Hepatitis C Treatment Response.
about
The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control Study.Efficacy of 24-week pegylated interferon alpha and ribavirin combination therapy in highly selected patients infected with hepatitis C virus genotype 1.Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patientsDistribution of IL28B Genotypes in Iranian Patients with Chronic Hepatitis C and Healthy Individuals.The Role of Polymorphisms Near the IL28B Gene on Response to Peg-Interferon and Ribavirin in Thalassemic Patients With Hepatitis C.Comparison of Three Different Methods for Detection of IL28 rs12979860 Polymorphisms as a Predictor of Treatment Outcome in Patients with Hepatitis C Virus.The Prevalence of Hepatitis C Virus Core Amino Acid 70 Substitution and Genotypes of Polymorphisms Near the IFNL3 Gene in Iranian Patients With Chronic Hepatitis C.Lack of association between interleukin 28B gene polymorphisms (rs8099917G/T, rs12979860 C/T) and susceptibility to chronic hepatitis C virus infection, Tehran, Iran.The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C.Allele and Genotype Frequency of IL28B (rs12979860) in South Iranian population.IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients.
P2860
Q34546135-5FC8B6D9-0A25-4D6D-AB72-B13DAE250684Q35089901-7636AC43-D87D-4C77-AAD6-0C58C55D85DEQ35925546-091576EB-4334-4C04-9B8B-B4D05CC35756Q36634420-9123FB74-AE43-4FDD-A824-A1E34AE265AEQ36805359-95873125-C224-4ABE-8999-8AA607F554D8Q36850395-C81979C9-EDA8-42BB-BDA3-0A44FC91231CQ37231215-95A97F78-F547-4F2D-9664-5E87B95ECB5DQ37643650-AD96973B-31D4-4F19-BA65-F5FEA58FE1B5Q40428595-5412E0CC-4AA0-4643-90B6-EDC1F3F21695Q41831480-8E3BDAC5-09C5-49FC-83A9-6EDE40BA114CQ54263185-DCA51E80-36C1-4A11-94A2-8E6C7BE8B813
P2860
Development and Validation of a Simple, Rapid and Inexpensive PCR-RFLP Method for Genotyping of Common IL28B Polymorphisms: A Useful Pharmacogenetic Tool for Prediction of Hepatitis C Treatment Response.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Development and Validation of ...... epatitis C Treatment Response.
@en
Development and Validation of ...... epatitis C Treatment Response.
@nl
type
label
Development and Validation of ...... epatitis C Treatment Response.
@en
Development and Validation of ...... epatitis C Treatment Response.
@nl
prefLabel
Development and Validation of ...... epatitis C Treatment Response.
@en
Development and Validation of ...... epatitis C Treatment Response.
@nl
P2093
P2860
P356
P1433
P1476
Development and Validation of ...... Hepatitis C Treatment Response
@en
P2093
Ali Pouryasin
Bita Behnava
Heidar Sharafi
Leila Mehrnoush
Osveh Kheradvar
Shima Salimi
P2860
P304
P356
10.5812/HEPATMON.849
P407
P577
2012-03-28T00:00:00Z